leadf
logo-loader
AIM:GDR

Genedrive PLC

Receive alerts
Market:
AIM
Market Cap:
£25.91 m
Price
41.00 GBX
Change
-2.38%
52 weeks high
302.60
52 weeks low
6.25

Genedrive® development has been validated through a range of applications and external independent evaluations. The Genedrive® HCV-ID test has received CE-IVD Certification and has been launched in Africa and the Asia Pacific region. genedrive plc has distribution agreements with subsidiaries of Sysmex Corporation for the distribution of the Genedrive® platform in the EMEA and selected countries of the Asia Pacific region, and with ARKRAY Healthcare pvt Ltd for the distribution of the Genedrive® HCV ID Kit and Genedrive® platform in India. The company also has an active development programme underway for Tuberculosis detection and drug resistance assessment.

genedrive plc is based in Manchester, United Kingdom. The business was floated on the London AIM market in 2007, trading as Epistem Holdings Inc. With an historical founding in the provision of contract research services to Pharmaceutical and Biotech companies, the business was renamed genedrive plc in July 2016 to reflect the new direction of the company targeting molecular diagnostic requirements at the point of need. The legacy contract research services divisions were divested in June 2018.

United Kingdom.

Ian Gilham

Ph.D., Non-Executive Chairman

Ian was appointed a Director on 24 November 2014 and as Non-Executive Chairman on 11 May 2015. He is also Non-Executive Chairman of two life sciences companies: AIM-quoted Horizon Discovery Group Plc, which provides gene-editing tools to support translational genomics and the development of personalised medicine; and Cytox Group Limited who provide risk assessment and stratification tools for Alzheimers disease and dementia. Dr Gilham was formerly Chief Executive Officer of Axis-Shield Plc.

David Budd

Chief Executive Officer

David was appointed a Director and Chief Executive on March 1, 2016. He has over 20 years of international commercial and operational experience in the diagnostics and medical devices field.  He previously served as General Manager of Leica Biosystems Amsterdam and Commercial Director at Leica Biosystems Newcastle, with global responsibility for marketing, product development, and commercial launches for diagnostic tests. Prior to Leica, David’s roles included Point-of-Care, molecular, and central laboratory marketing and commercialisation responsibilities at Siemens Healthcare Diagnostics, Bayer Diagnostics, and Visible Genetics.

Matthew Fowler

Chief Financial Officer

Matthew was appointed Chief Financial Officer on December 13th 2016. He has over 15 years of experience in senior positions in the manufacturing, power and support services industries. Prior to joining genedrive, Matthew spent eight years as Group Financial Controller of Scapa Group plc, a multinational manufacturing AIM-quoted business. At Scapa Group plc, Matthew was responsible for shaping and managing finance within the Group as well as strategy development and other core processes. Prior to that, Matthew spent three years at British Nuclear Group as Finance Manager where he managed the corporate centre's finance team and was responsible for planning, reporting and accounting. Matthew trained and qualified in the audit department of Deloitte & Touche.

Tom Lindsay

Non-Executive Director

Tom has 35 years of global sales and marketing experience in the diagnostics sector. He most recently worked for Alere Inc. in Africa for 11 years before retiring in 2017.  At Alere he held a range of executive posts including President of Africa, President Commercial Operations for Africa, and Business Development Director for Africa; and led the introduction and successful commercialisation of a number of key HIV screening and HIV patient management point of care diagnostics technologies.

Prior to joining Alere Inc., Tom held senior commercial roles at Trinity Biotech (Ireland) including Marketing and Sales Director (Global) and Business Development Director for Africa, Middle East and India. Trinity Biotech specialises in the development, manufacture and marketing of diagnostic test kits.

Tom studied Microbiology at Glasgow Caledonian University and completed a National Diploma in Microbiology at the South African Institute of Medical Research in Johannesburg, South Africa.

Chris Yates

Non-executive Director, Chairman of the Audit Committee

Chris was appointed to Board on 22 August 2018.  He is currently CEO of Abingdon Health, a position he has held since July 2015.  Chris co-founded Abingdon in 2008 and was a non-executive of the company prior to his appointment as CEO.  Chris has over 20 years experience of working in listed environments and prior to working at Abingdon, was CFO at Immunodiagnostic Systems Holdings PLC and Cozart plc.  Chris is a Chartered Accountant and has a degree in economics from Cambridge University.

Contact Details

genedrive plc
48 Grafton Street
Manchester
M13 9XX
UK

For further information:   support@genedrive.com

Tel: +44 (0)161 989 0245

Registered Office:
The Incubator Building
Grafton Street
Manchester
M13 9XX

Registered in England and Wales

Company No. 06108621

Company Secretary

Matthew Fowler
48 Grafton Street
Manchester M3 9XX

Principal Bankers

Natwest Commercial Banking
5th Floor, 1 Spinningfields Square
Deansgate
Manchester M3 3AP

Nominated Advisor and Broker

Peel Hunt LLP
120 London Wall
London 
EC2Y 5ET

Registrars

Neville Registrars Limited
18 Laurel Lane
Halesowen
B63 3DA

Auditors

PriceWaterhouseCoopers LLP
Chartered Accountants and Statutory Auditors
101 Barbirolli Square
Lower Mosley Street
Manchester M2 3PW

Legal Advisors

Addleshaw Goddard LLP
Cornerstone
107 West Regent Street
Glasgow G2 2BA

Financial PR and Communications

Walbrook PR Ltd
4 Lombard Street
London
EC3V 9HD

Investor Relations

Stanford Capital Partners Ltd
Head Office 15-17 Eldon Street
London
EC2M 7LD

Click here for information on major shareholders.

Company Secretary

Matthew Fowler
48 Grafton Street
Manchester M3 9XX

Principal Bankers

Natwest Commercial Banking
5th Floor, 1 Spinningfields Square
Deansgate
Manchester M3 3AP

Nominated Advisor and Broker

Peel Hunt LLP
120 London Wall
London 
EC2Y 5ET

Registrars

Neville Registrars Limited
18 Laurel Lane
Halesowen
B63 3DA

Auditors

PriceWaterhouseCoopers LLP
Chartered Accountants and Statutory Auditors
101 Barbirolli Square
Lower Mosley Street
Manchester M2 3PW

Legal Advisors

Addleshaw Goddard LLP
Cornerstone
107 West Regent Street
Glasgow G2 2BA

Financial PR and Communications

Walbrook PR Ltd
4 Lombard Street
London
EC3V 9HD

Investor Relations

Stanford Capital Partners Ltd
Head Office 15-17 Eldon Street
London
EC2M 7LD